Obstacles and opportunities for understanding macrophage polarization
Tóm tắt
Macrophages are now routinely categorized into phenotypic subtypes based on gene expression induced in response to cytokine and pathogen-derived stimulation. In the broadest division, macrophages are described as being CAMs (M1 macrophages) or AAMs (M2 macrophages) based on their exposure to TLR and IFN signals or Th2 cytokines, respectively. Despite the prolific use of this simple classification scheme, little is known about the precise functions of effector molecules produced by AAMs, especially how representative the CAM and AAM subtypes are of tissue macrophages in homeostasis, infection, or tissue repair and how plasticity in gene expression regulates macrophage function in vivo. Furthermore, correlations between mouse and human tissue macrophages and their representative subtypes are lacking and are a major barrier to understanding human immunity. Here, we briefly summarize current features of macrophage polarization and discuss the roles of various macrophage subpopulations and macrophage-associated genes in health and disease.
Từ khóa
Tài liệu tham khảo
Gordon, 2010, Alternative activation of macrophages: mechanism and functions, Immunity, 32, 593, 10.1016/j.immuni.2010.05.007
Hume, 2008, Macrophages as APC and the dendritic cell myth, J. Immunol., 181, 5829, 10.4049/jimmunol.181.9.5829
Mantovani, 2010, Macrophages, innate immunity and cancer: balance, tolerance, and diversity, Curr. Opin. Immunol., 22, 231, 10.1016/j.coi.2010.01.009
Martinez, 2009, Alternative activation of macrophages: an immunologic functional perspective, Annu. Rev. Immunol., 27, 451, 10.1146/annurev.immunol.021908.132532
Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat. Rev. Immunol., 8, 958, 10.1038/nri2448
Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007
Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014
Biswas, 2010, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nat. Immunol., 11, 889, 10.1038/ni.1937
Biswas, 2008, Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms, J. Immunol., 180, 2011, 10.4049/jimmunol.180.4.2011
Goerdt, 1999, Other functions, other genes: alternative activation of antigen-presenting cells, Immunity, 10, 137, 10.1016/S1074-7613(00)80014-X
Gratchev, 2006, Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals, Immunobiology, 211, 473, 10.1016/j.imbio.2006.05.017
Stout, 2005, Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences, J. Immunol., 175, 342, 10.4049/jimmunol.175.1.342
Stout, 2004, Functional plasticity of macrophages: reversible adaptation to changing microenvironments, J. Lukoc. Biol., 76, 509, 10.1189/jlb.0504272
Stout, 2009, Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages, J. Leukoc. Biol., 86, 1105, 10.1189/jlb.0209073
Modolell, 1995, Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines, Eur. J. Immunol., 25, 1101, 10.1002/eji.1830250436
Mylonas, 2009, Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing, J. Immunol., 182, 3084, 10.4049/jimmunol.0803463
Rutschman, 2001, Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production, J. Immunol., 166, 2173, 10.4049/jimmunol.166.4.2173
Wells, 2003, Genetic control of the innate immune response, BMC Immunol., 4, 5, 10.1186/1471-2172-4-5
Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm, J. Immunol., 164, 6166, 10.4049/jimmunol.164.12.6166
Way, 2009, The generation and properties of human macrophage populations from hemopoietic stem cells, J. Leukoc. Biol., 85, 766, 10.1189/jlb.1108689
El Kasmi, 2006, General nature of the STAT3-activated anti-inflammatory response, J. Immunol., 177, 7880, 10.4049/jimmunol.177.11.7880
Lang, 2002, Shaping gene expression in activated and resting primary macrophages by IL-10, J. Immunol., 169, 2253, 10.4049/jimmunol.169.5.2253
Ovchinnikov, 2010, A conserved distal segment of the mouse CSF-1 receptor promoter is required for maximal expression of a reporter gene in macrophages and osteoclasts of transgenic mice, J. Leukoc. Biol., 87, 815, 10.1189/jlb.0809557
Schneemann, 2007, Macrophage biology and immunology: man is not a mouse, J. Leukoc. Biol., 81, 579, 10.1189/jlb.1106702
Schneemann, 2002, Species differences in macrophage NO production are important, Nat. Immunol., 3, 102, 10.1038/ni0202-102a
Nathan, 2006, Role of iNOS in human host defense, Science, 312, 1874, 10.1126/science.312.5782.1874b
Choi, 2002, Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis, Am. J. Respir. Crit. Care Med., 166, 178, 10.1164/rccm.2201023
Munder, 2009, Arginase: an emerging key player in the mammalian immune system, Br. J. Pharmacol., 158, 638, 10.1111/j.1476-5381.2009.00291.x
Munder, 2005, Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity, Blood, 105, 2549, 10.1182/blood-2004-07-2521
Munder, 2006, Suppression of T-cell functions by human granulocyte arginase, Blood, 108, 1627, 10.1182/blood-2006-11-010389
Raes, 2005, Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells, J. Immunol., 174, 6561, 10.4049/jimmunol.174.11.6561
Coers, 2009, Modeling infectious disease in mice: co-adaptation and the role of host-specific IFNγ responses, PLoS Pathog., 5, e1000333, 10.1371/journal.ppat.1000333
Hargreaves, 2009, Control of inducible gene expression by signal-dependent transcriptional elongation, Cell, 138, 129, 10.1016/j.cell.2009.05.047
Medzhitov, 2009, Transcriptional control of the inflammatory response, Nat. Rev. Immunol., 9, 692, 10.1038/nri2634
Ramirez-Carrozzi, 2009, A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling, Cell, 138, 114, 10.1016/j.cell.2009.04.020
Saraiva, 2010, The regulation of IL-10 production by immune cells, Nat. Rev. Immunol., 10, 170, 10.1038/nri2711
Loke, 2002, IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype, BMC Immunol., 3, 7, 10.1186/1471-2172-3-7
Nair, 2003, Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro, Immunol. Lett., 85, 173, 10.1016/S0165-2478(02)00225-0
Zimmermann, 2003, Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis, J. Clin. Invest., 111, 1863, 10.1172/JCI17912
Siracusa, 2008, Dynamics of lung macrophage activation in response to helminth infection, J. Leukoc. Biol., 84, 1422, 10.1189/jlb.0308199
Zhang, 2010, Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines, PLoS Negl. Trop. Dis., 4, e648, 10.1371/journal.pntd.0000648
Sandler, 2003, Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair, J. Immunol., 171, 3655, 10.4049/jimmunol.171.7.3655
Stütz, 2003, The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule α gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism, J. Immunol., 170, 1789, 10.4049/jimmunol.170.4.1789
Herbert, 2004, Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology, Immunity, 20, 623, 10.1016/S1074-7613(04)00107-4
Albina, 2005, Macrophage arginase regulation by CCAAT/enhancer-binding protein β, Shock, 23, 168, 10.1097/01.shk.0000148054.74268.e2
El Kasmi, 2008, Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens, Nat. Immunol., 9, 1399, 10.1038/ni.1671
Gray, 2005, Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ, Gene, 353, 98, 10.1016/j.gene.2005.04.004
Munder, 1999, Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells, J. Immunol., 163, 3771, 10.4049/jimmunol.163.7.3771
Pauleau, 2004, Enhancer-mediated control of macrophage-specific arginase I expression, J. Immunol., 172, 7565, 10.4049/jimmunol.172.12.7565
Herbert, 2010, Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis, J. Immunol., 184, 6438, 10.4049/jimmunol.0902009
Corraliza, 1995, Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages, Biochem. Biophys. Res. Commun., 206, 667, 10.1006/bbrc.1995.1094
Mori, 1998, Regulation of the urea cycle enzyme genes in nitric oxide synthesis, J. Inherit. Metab. Dis., 21, 59, 10.1023/A:1005357608129
Qualls, 2010, Sci. Signal.
Saeij, 2007, Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue, Nature, 445, 324, 10.1038/nature05395
Pesce, 2009, Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis, PLoS Pathog., 5, e1000371, 10.1371/journal.ppat.1000371
Liu, 2004, FIZZ1 stimulation of myofibroblast differentiation, Am. J. Pathol., 164, 1315, 10.1016/S0002-9440(10)63218-X
Li, 2005, Upregulation of hypoxia-induced mitogenic factor in compensatory lung growth after pneumonectomy, Am. J. Respir. Cell Mol. Biol., 32, 185, 10.1165/rcmb.2004-0325OC
Pesce, 2009, Retnla (relmα/fizz1) suppresses helminth-induced Th2-type immunity, PLoS Pathog., 5, e1000393, 10.1371/journal.ppat.1000393
Nair, 2009, Alternatively activated macrophage-derived RELM-{α} is a negative regulator of type 2 inflammation in the lung, J. Exp. Med., 206, 937, 10.1084/jem.20082048
Burnett, 2006, Development of peritoneal adhesions in macrophage depleted mice, J. Surg. Res., 131, 296, 10.1016/j.jss.2005.08.026
Saxena, 2007, The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse, J. Immunol., 179, 5041, 10.4049/jimmunol.179.8.5041
Dai, 2002, Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects, Blood, 99, 111, 10.1182/blood.V99.1.111
MacDonald, 2010, An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation, Blood, 116, 3955, 10.1182/blood-2010-02-266296
Clausen, 1999, Conditional gene targeting in macrophages and granulocytes using LysMcre mice, Transgenic Res., 8, 265, 10.1023/A:1008942828960
Takeda, 1999, Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils, Immunity, 10, 39, 10.1016/S1074-7613(00)80005-9
Bell, 2008, The earliest thymic progenitors for T cells possess myeloid lineage potential, Nature, 452, 764, 10.1038/nature06840
Faust, 2000, Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages, Blood, 96, 719, 10.1182/blood.V96.2.719.014k29_719_726
Ye, 2003, Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential, Immunity, 19, 689, 10.1016/S1074-7613(03)00299-1